Skip to main content

Find Clinical Trials

Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Not Yet Recruiting

A Real-world Study on Golidocitinib-based Therapeutic Regimens for the Treatment of Patients With Peripheral T-cell Lymphoma

NCT06963632

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Combining Electrical Impedance Tomography and Thoracic Ultrasound Toinvestigate Dynamic Changes

NCT06958770

Conditions: ARDS (Moderate or Severe), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma

NCT06956092

Conditions: B Cell Lymphoma (BCL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: The First Affiliated Hospital of Zhengzhou University, Department of Oncology Zhengzhou, Henan, China

View Trial Details

Not Yet Recruiting

Zanubrutinib Combined With BR in the First-line Treatment of Waldenström's Macroglobulinemia

NCT06942507

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Not Yet Recruiting

Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis

NCT06951971

Conditions: Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis (HLH), Histiocytosis, +3 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma

NCT06918015

Conditions: BTK Inhibitors, Follicular Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

A Study of R-mini-MCOP in the Treatment of Elderly, Previously Untreated DLBCL

NCT06921044

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin Lymphoma

NCT06919679

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +21 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma

NCT06045195

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: 1st Department of Medicine, Cologne University Hospital Cologne, Germany

View Trial Details

Not Yet Recruiting

Eosinophil Subpopulations in Eosinophilic-associated Diseases

NCT06911775

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +22 more
Locations: Not specified

View Trial Details